Pila Pharma AB Cash Flow Conversion Efficiency

Latest as of December 2025: -0.095x

Pila Pharma AB cash flow conversion efficiency. Based on the latest financial reports, Pila Pharma AB (PILA) has a cash flow conversion efficiency ratio of -0.095x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-1.41 Million ≈ $-151.76K USD) by net assets (Skr14.78 Million ≈ $1.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Pila Pharma AB (2018–2025)

Cash flow conversion efficiency of Pila Pharma AB from 2018 to 2025. This chart illustrates how Pila Pharma AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View PILA stock price for real-time trading data and today's change.

Pila Pharma AB Cash Flow Conversion Ratio Explained

Pila Pharma AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Pila Pharma AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pila Pharma AB ranked by their cash flow conversion efficiency. Also see PILA company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Adelong Gold Ltd AU:ADG	-0.066x
Avrasya Petrol ve Turistik Tesisler Yatirimlar AS IS:AVTUR	0.010x
PRS Reit PLC LSE:PRSR	0.016x
Zacatecas Silver Corp V:ZAC	-0.018x
DXN Ltd AU:DXN	-0.368x
WALKER RIVER RES CORP F:1WV0	-0.019x
CYL Corporation Bhd KLSE:7157	0.081x
Weha Transportasi Indonesia TBK JK:WEHA	0.069x

Annual Cash Flow Conversion Efficiency for Pila Pharma AB (2018–2025)

The table below shows the annual cash flow conversion efficiency of Pila Pharma AB from 2018 to 2025. Review PILA free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr14.78 Million ≈ $1.59 Million	Skr-9.19 Million ≈ $-988.56K	-0.621x	+58.21%
2024-12-31	Skr5.26 Million ≈ $566.17K	Skr-7.82 Million ≈ $-841.88K	-1.487x	-104.07%
2023-12-31	Skr6.66 Million ≈ $716.87K	Skr-4.85 Million ≈ $-522.37K	-0.729x	+23.61%
2022-12-31	Skr9.53 Million ≈ $1.03 Million	Skr-9.09 Million ≈ $-978.34K	-0.954x	-208.63%
2021-12-31	Skr30.30 Million ≈ $3.26 Million	Skr-9.36 Million ≈ $-1.01 Million	-0.309x	+47.16%
2020-12-31	Skr3.42 Million ≈ $368.07K	Skr-2.00 Million ≈ $-215.30K	-0.585x	+13.15%
2019-12-31	Skr7.46 Million ≈ $802.59K	Skr-5.02 Million ≈ $-540.56K	-0.674x	+4.17%
2018-12-31	Skr6.49 Million ≈ $698.79K	Skr-4.56 Million ≈ $-491.12K	-0.703x	--

About Pila Pharma AB

ST:PILA Sweden Biotechnology

Market Cap

$7.55 Million

Skr70.12 Million SEK

Market Cap Rank

#27620 Global

#598 in Sweden

Share Price

Skr1.54

Change (1 day)

+8.87%

52-Week Range

Skr1.10 - Skr2.41

All Time High

Skr12.40